Marketing Information

- It clearly explains the therapeutic value of these molecules: It presents the
evidence as to why these molecules are capable of significantly accelerating
the psychotherapeutic process, representing an imminent paradigm shift in
mental health.
- Current hot topic: It allows us to understand why the FDA (USA) has
granted these therapies the status of "breakthrough therapies" to
accelerate research and why new psychedelics assisted therapies are in the
crosshairs of legislators, of the media and investors.
- It will help health professionals get up to speed on the current state of
these new therapies, cutting-edge clinical studies, and the
psychotherapeutic mechanisms of action of the molecules.
- The reader will learn how the brain generates reality and our identity and
how psychedelic molecules are capable of weakening the ego's defensive
barriers and allowing a vision of oneself "from afar" that opens a window of
flexibility and allows profound revelations.
- Helps personal growth: Explains why these molecules can facilitate the
psychotherapeutic process of personal growth and help us leave behind
parts of ourselves that no longer serve us.
- The annex on legality, written by an expert lawyer, clearly answers the most
relevant doubts about legislation.

Reviews

“Irene de Caso explains in an understandable and entertaining way the current
neuroscientific advances related to psychedelic drugs, as well as their clinical and
experiential applications.”

-José Carlos Bouso, PhD, Scientific Director, ICEERS.

Author Biography

Biologist, specialized in neuroscience at the University Complutense of Madrid.
Master and PhD in Cognitive Neuroscience and Neuroimaging at the University
of York, studying the relationship between executive functions, self-focused
attention and brain connectivity, under the supervision of Jonathan Smallwood.
Master in Mindfulness Applied to Mental Health. Co-organiser of the 2020
Interdisciplinary Conference on Psychedelic Research. R&D team member
at the Amsterdam Psychedelic Research Association, and administrator and
community manager of Madrid’s Psychedelic Society.